This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

HARRY M. ROBINSON, M.D.

AMA Arch Derm Syphilol. 1951;64(5):565-572.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN JUNE, 1947, chloramphenicol¹ was first given to a patient with chronic discoid lupus erythematosus. All of the other currently advocated drugs (gold sodium thiosulfate, bismuth by mouth and by intramuscular injection, and paraaminobenzoic acid) had given such uniformly poor results that this antibiotic drug was tried in the hope that it might prove of greater value than the others.

The improvement in the lesions in the first patient treated was so noticeable and rapid (within one week) that it was decided to continue the treatment for this patient, and 12 more patients with the same disease were added, making a group of 13 under treatment. Patients were given 1 or 1.25 gm. of chloramphenicol divided into four or five doses of 250 mg. each.

The results at that time seemed of sufficient academic interest to warrant a preliminary report.² All of these patients have now been followed . . . [Full Text PDF of this Article]

Author Affiliations
BALTIMORE

From the Department of Dermatology, School of Medicine, University of Maryland.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?